Is APTCF or XYLD a better dividend investment in 2026?

APTCF currently yields 1000000.00% with a 5% 5-year dividend growth rate. XYLD yields 11.20% with 0.5% growth. The better choice depends on your goal: APTCF offers higher current income.

What is the dividend yield difference between APTCF and XYLD?

APTCF has a forward dividend yield of 1000000.00% ($2.00/share annually). XYLD yields 11.20% ($4.30/share annually). The yield gap is 999988.80 percentage points.

Home › Compare › APTCF vs XYLD

APTCF vs XYLD: Dividend Comparison 2026

APTCF yields 1000000.00% · XYLD yields 11.20%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 APTCF wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

APTCF

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full APTCF calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

11.20%

Share price

$38.36

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$3,351.03

Full XYLD calculator →

Portfolio growth — APTCF vs XYLD

📍 APTCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	APTCF	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, APTCF + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

APTCF pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APTCF

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

XYLD

Annual income on $10K today (after 15% tax)

$952.37/yr

After 10yr DRIP, annual income (after tax)

$2,848.38/yr

At 15% tax rate, APTCF beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APTCF + XYLD for your $10,000?

APTCF: 50%XYLD: 50%

100% XYLD50/50100% APTCF

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APTCF buys

XYLD buys

No recent congressional trades found for APTCF or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAPTCFXYLD

Forward yield	1000000.00% ✓	11.20%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.7683925249533696e+36M	$25.9K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$3,351.03
Total dividends collected	$4.7683311610149396e+36M	$20.2K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: APTCF vs XYLD ($10,000, DRIP)

Year	APTCF Portfolio	APTCF Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$10,840	$1,120.44	+$100.00M → APTCF
2	$934,786,450,701	$934,679,439,252.34	$11,786	$1,249.59	+$934786.44M → APTCF
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$12,854	$1,397.78	+$8165787108.57M → APTCF
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$14,063	$1,568.33	+$66665884190957.63M → APTCF
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$15,434	$1,765.19	+$508662171058048128.00M → APTCF
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$16,995	$1,993.14	+$3.62723524842849e+21M → APTCF
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$18,777	$2,257.95	+$2.417368115915061e+25M → APTCF
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$20,818	$2,566.58	+$1.5056740286145463e+29M → APTCF
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$23,163	$2,927.50	+$8.764771002818475e+32M → APTCF
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$25,865	$3,351.03	+$4.7683925249533696e+36M → APTCF

APTCF vs XYLD: Complete Analysis 2026

APTCF — Stock

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.

Full APTCF Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this APTCF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APTCF vs SCHD APTCF vs JEPI APTCF vs O APTCF vs KO APTCF vs MAIN APTCF vs QYLD APTCF vs JEPQ APTCF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.